Abstract
April 9, 2020 marks 100 days since the first cases of coronavirus disease 2019 in China. In this crucial day with 1 436 198 confirmed infected cases in the world and 85 521 deaths, the Global Level of the Covid-19 pandemic was evaluated at very high according to the World Health Organization (WHO) situation report. For most people, COVID-19 infection will cause mild illness (fever and at least one symptom of respiratory disease); however, for more than 3.4% of people, it can be fatal. Older people and those with preexisting medical conditions (such as cardiovascular disease, chronic respiratory disease, or diabetes) are at risk of severe disease and mortality. The incubation period of the virus is estimated to be between 2 and 14 days, but longer incubation had been reported. Furthermore, data published by world authorities show that statistics are different for different geographical regions and depend on many social and environmental factors. The sad reality of the COVID-19 is that there are currently no medications or vaccines proven to be effective for the treatment or prevention of the disease. The pandemic spread is consequenctly followed by a worldwide panic. Facing this dramatic uncertain situation, implementing a country-wide strategy for social distancing and a general logistic policy for critical and life-saving supplies is an urgent for government and sanitary authorities. Several mathematical models have been proposed to predict epidemic spread. However, models should be adapted to specific situations in countries where geographic, societal, economic, and political strategies are different. Here, we propose the application of the well-known SIR model to the case study of Tunisia for which data are collected from three databases in order to have rapidly predict the situation. Such results can be useful in the future to design a more reliable model to help in monitoring infection control.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors declare that they have no known competing financial interests or personal relationships that have, or could be perceived to have influenced the work reported in this article.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data can be retrieved from the public repository: Mendeley Data Data identification number: 10.17632/v8fhn6wsh2.3 Direct URL to data: https://data.mendeley.com/datasets/v8fhn6wsh2/3
